Menu Search
Equities

Aceso Life Science Group Ltd

474:HKG.HZ

Aceso Life Science Group Ltd

Actions
  • Price (HKD)0.057
  • Today's Change-0.003 / -5.00%
  • Shares traded2.29m
  • 1 Year change-62.50%
  • Beta--
Data delayed at least 15 minutes, as of Nov 06 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Aceso Life Science Group Ltd is an investment holding company engaged in the sale of construction machinery and spare parts. The Company operates its business through six segments. Rental and Sales of Construction Machinery and Spare Parts segment engages in the sale of construction machinery, spare parts and construction materials, and provision of construction machinery rental services. Property Leasing segment engages in the leasing of commercial properties. Money Lending segment provides mortgage loans and personal loans in Hong Kong. Provision of Asset Management, Securities Brokerage, Commodities, Futures and Other Financial Services segment engages in the securities, futures trading, asset management, wealth management and others. Provision of Repair and Maintenance and Transportation Services segment provides repair and maintenance services of construction machinery and transportation services. Property Development segment engages in the development of property.

  • Revenue in HKD (TTM)228.00m
  • Net income in HKD-462.00m
  • Incorporated2005
  • Employees151.00
  • Location
    Aceso Life Science Group LtdUnit 4803, 48/F, COSCO Tower183 Queen’s Road Central Hong KongHKG
  • Phone+852 31608466
  • Fax+852 31608455
  • Websitehttp://www.acesogrouphk.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.